• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Hyderabad, April 6

Wanbury Ltd, the world's largest manufacturer of Metformin, a diabetes management product, announced that it has commissioned a new unit at its recently acquired facility at Tanuku in Andhra Pradesh. In a press release, the company said the commissioning marked the completion of the first phase of planned capacity expansion programme. In this phase, Wanbury would be manufacturing three high value products — Sertraline, Paroxetine and Carvedilol, which have a strong market.

According to the company, the second phase of expansion would be completed by August in which 4-6 new products would be added to the existing product portfolio. With capacity expansion, estimated at a cost of Rs 25 crore, the company expected to add more than Rs 100 crore to its topline. The Tanuku facility has a multi product approval from the United States Food and Drug Administration (USFDA) and has also undergone plant inspections by leading MNCs for outsourcing various products.

More Stories on : New Projects | Pharmaceuticals | Andhra Pradesh

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Strengthening of Koyna Dam spillway to be completed by May

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line